● Pharmacogenetics
-
ALDH Genetic Polymorphism
Setsi sena se sebelisetsoa ho lemoha boleng ba in vitro ea sebaka sa ALDH2 sa G1510A polymorphism ho DNA ea mali ea motho.
-
Motho CYP2C9 le VKORC1 Gene Polymorphism
Kit ena e sebetsa ho in vitro qualitative discovery of polymorphism of CYP2C9*3 (rs1057910, 1075A>C) le VKORC1 (rs9923231, -1639G>A) ho DNA ea genomic ea lisampole tsa mali a motho kaofela.
-
Motho CYP2C19 Gene Polymorphism
Sesebelisoa sena se sebelisetsoa ho lemoha boleng ba in vitro polymorphism ea liphatsa tsa lefutso tsa CYP2C19 CYP2C19 * 2 (rs4244285, c.681G> A), CYP2C19 * 3 (rs4986893, c.636G> A), CYP2C19> 2 c6.5 inrs. Genomic DNA ea lisampole tsa mali a motho.
-
Human Leukocyte Antigen B27 Nucleic Acid
Setsi sena se sebelisetsoa ho lemoha boleng ba DNA ho batho ba leukocyte antigen subtypes HLA-B * 2702, HLA-B * 2704 le HLA-B * 2705.
-
MTHFR Gene Polymorphic Nucleic Acid
Sesebelisoa sena se sebelisetsoa ho bona libaka tse 2 tsa phetoho ea mofuta oa MTHFR. Thepa e sebelisa mali a motho kaofela e le sampole ea teko ho fana ka tlhahlobo ea boleng ba boemo ba phetoho. E ka thusa baoki ho etsa merero ea kalafo e loketseng litšobotsi tse fapaneng tsa motho ka mong ho tloha boemong ba limolek'hule, e le ho netefatsa bophelo bo botle ba bakuli ho isa tekanyong e kholo.
